Outlook Therapeutics Announces $25 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
ISELIN, N.J., Dec. 23, 2022 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical…
ISELIN, N.J., Dec. 23, 2022 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical…
OSLO, Norway, Dec. 23, 2022 (GLOBE NEWSWIRE) — Nykode Therapeutics ASA (OSE: NYKD), a clinical-stage…
NEW YORK & OSLO & LUXEMBOURG–(BUSINESS WIRE)–FREYR Battery (NYSE: FREY) (“FREYR” or “the Company”), a…
DUBLIN–(BUSINESS WIRE)–The “USA Used Car Market Outlook to 2026 – Driven by An Influx of…
BioNTech aims to develop the first mRNA-based vaccine for Malaria prevention based on a novel…
Total considerations of up to USD 83 million with the majority secured for Phase 2…
Montrouge, France, December 23, 2022 DBV Technologies Announces FDA Has Lifted Partial Clinical Hold on…
Japanese regulatory authority granted marketing authorization to Basilea’s license partner, Asahi Kasei Pharma Intravenous and…
Saint-Herblain (France), December 23, 2022 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty…
Internet City, Dubai–(Newsfile Corp. – December 23, 2022) – LBank Exchange, a global digital asset…
Internet City, Dubai–(Newsfile Corp. – December 23, 2022) – LBank Exchange, a global digital asset…
HONG KONG, Dec 23, 2022 – (ACN Newswire) – Shares of OrbusNeich Medical Group Holdings…
PETALING JAYA, Malaysia, Dec 23, 2022 – (ACN Newswire) – Samaiden Group Berhad (Bursa: SAMAIDEN,…
TOKYO, Dec 23, 2022 – (JCN Newswire) – Fujitsu today announced that it will start…
NEW YORK, Dec. 22, 2022 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in…
Kuala Lumpur, Malaysia–(Newsfile Corp. – December 22, 2022) – Finxeed, the decentralized credibility scoring platform,…
PHILADELPHIA–(BUSINESS WIRE)–Today, Delaware Investments National Municipal Income Fund (the “Fund”), a New York Stock Exchange…
– Similar clinical remission rates observed in patients receiving AMT-101 monotherapy compared to placebo at…
NEW YORK, Dec. 22, 2022 (GLOBE NEWSWIRE) — Intelligent Bio Solutions Inc. (Nasdaq: INBS) (the…
SOUTH SAN FRANCISCO, Calif., Dec. 22, 2022 (GLOBE NEWSWIRE) — CytomX Therapeutics, Inc. (Nasdaq: CTMX),…